Intimation of receipt of certified true copy of merger order from Hon''ble NCLT Bench Mumbai.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innovassynth Investments Limited (BSE: 533315) has received the certified true copy of the NCLT Mumbai Bench order dated November 14, 2025, along with a rectification order dated November 26, 2025, sanctioning the merger by absorption of Innovassynth Technologies (India) Limited (ITIL, the unlisted operating company in specialty chemicals and pharmaceutical intermediates) with itself (IIL, the listed investment company). The swap ratio is 1:1 — one equity share of ₹10 in IIL for every one equity share of ₹10 held in ITIL, with Appointed Date of October 1, 2024. Shareholders of ITIL approved the scheme with 100% consent, while IIL shareholders approved it with 95.07% by value and 96.26% by number. Upon effectiveness, IIL will be renamed 'Innovassynth Technologies (India) Limited' and will absorb the entire business, assets, and liabilities of ITIL. The scheme becomes effective only after the certified order is filed with the Registrar of Companies, Mumbai.
For shareholders of IIL, this is a value-unlocking event as the listed shell will absorb the operating specialty chemicals business, potentially improving trading liquidity and fundamental value. The share count will increase due to new shares issued to ITIL shareholders (other than IIL itself), which could lead to short-term dilution. The merger is not yet effective pending ROC filing.